Halozyme Therapeutics
HALO
#2202
Rank
S$9.43 B
Marketcap
$76.60
Share price
-0.53%
Change (1 day)
58.05%
Change (1 year)

Earnings for Halozyme Therapeutics (HALO)

Earnings in 2024 (TTM): S$0.63 Billion

According to Halozyme Therapeutics's latest financial reports the company's current earnings are S$0.94 Billion. In 2023 the company made an earning of S$0.46 Billion, an increase over its 2022 earnings that were of S$0.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Halozyme Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.63 B36.63%
2023 S$0.46 B39.94%
2022 S$0.33 B0.16%
2021 S$0.33 B92.2%
2020 S$0.17 B-278.96%
2019 -S$96.32 Million-9.45%
2018 -S$0.11 Billion-229.51%
2017 S$82.12 M-160.48%
2016 -S$0.14 Billion216.03%
2015 -S$42.97 Million-52.86%
2014 -S$91.15 Million-18.09%
2013 -S$0.12 Billion55.88%
2012 -S$71.39 Million169.94%
2011 -S$26.45 Million-63.44%
2010 -S$72.33 Million-7.19%
2009 -S$77.93 Million15.91%
2008 -S$67.23 Million83.89%
2007 -S$36.57 Million78.1%
2006 -S$20.53 Million16%
2005 -S$17.7 Million45.24%
2004 -S$12.19 Million682.42%
2003 -S$1.56 Million1659.12%
2002 -S$0.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$33.37 M-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.53 B 2,014.28%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.22 B-65.42%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.25 B 1,346.18%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.87 B 1,443.00%๐Ÿ‡ซ๐Ÿ‡ท France
S$23.25 B 3,533.05%๐Ÿ‡บ๐Ÿ‡ธ USA